Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast [PDF]
, 2015 Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive.
Bellamy, C O, Harrison, D J
core +2 more sources
MicroRNA and histopathological characterization of pure mucinous breast carcinoma
Cancer Biology & Medicine, 2013 Objective: To evaluate the short-term outcomes of video-assisted thoracic surgery (VATS) for thoracic tumors. Methods: The data of 1,790 consecutive patients were retrospectively reviewed.
Fang Li +7 more
doaj +1 more source
Spindle Cell Metaplastic Breast Carcinoma with Leiomyoid Differentiation: A Case Report [PDF]
, 2011 Background: Metaplastic carcinoma of the breast is a rare but distinct entity within the group of undifferentiated invasive carcinomas. This entity accounts for less than 0.5% of all breast cancers and contains elements of epithelial (ductal ...
Jauch, Karl-Walter +11 more
core +1 more source
The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinoma [PDF]
, 2007 Aims: To clarify MUC1 patterns in invasive ductal breast carcinoma and to relate them to clinicopathological parameters, coexpression of other biological markers and prognosis.
de Bock, G. H. +10 more
core +2 more sources
The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. [PDF]
, 2008 Approximately 1 in every 600 women attending breast-screening programmes in the United Kingdom is diagnosed with breast carcinoma in situ (BCIS). However, there is little information on the occurrence of subsequent cancers (other than second breast ...
Holmberg, L +9 more
core +1 more source
Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast [PDF]
, 2008 Introduction To investigate the predictive value of clinical and biological markers for a pathological complete remission after a preoperative dose-dense regimen of doxorubicin and docetaxel, with or without tamoxifen, in primary operable breast cancer ...
Sinn, Hans-Peter +27 more
core +2 more sources
Pathological Features of Breast Cancer seen in Northwestern Tanzania: A Nine Years Retrospective Study. [PDF]
, 2011 Breast cancer is more common in Western Countries compared to African populations. However in African population, it appears that the disease tends to be more aggressive and occurring at a relatively young age at the time of presentation. The aim of this
Chalya Philipo L +11 more
core +1 more source
Primary squamous cell carcinoma of the breast: A case report in a review of current literature
Journal of Oncological Sciences, 2017 Primary squamous cell carcinoma of the breast is a rare malignancy considered a subtype of metaplastic breast carcinomas. Here we presented a case of 56-year-old female patient with a history of modified radical mastectomy, chemotherapy and radiotherapy ...
Ece Konuk +4 more
doaj +1 more source
A new model for ductal carcinoma in situ suggests strategies for treatment [PDF]
, 2002 Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor ...
Gullick, William J.
core +1 more source
Squamous cell carcinoma of the breast: a case report
World Journal of Surgical Oncology, 2008 Background Squamous cells are normally not found inside the breast, so a primary squamous cell carcinoma of the breast is an exceptional phenomenon. There is a possible explanation for these findings.
Hofstee Mans +2 more
doaj +1 more source